UBS Downgrades Teva Pharma (TEVA) to Neutral
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $35.01 -1.13%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
UBS downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $40.35 yesterday.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $40.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
- Kepler Cheuvreux Downgrades Avolta AG (AVOL:SW) to Hold
- Benchmark Downgrades Roblox Corp. (RBLX) to Sell, 'Ah Heck, Here We Go Again'
Create E-mail Alert Related Categories
DowngradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
